India, March 27 -- Hyderabad-based Dr. Reddy's Laboratories has entered into an exclusive partnership with Sanofi Healthcare India to promote and distribute their vaccine brands across private markets in India.

Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's well established and trusted paediatric and adult vaccine brands Hexaxim(R), Pentaxim(R), Tetraxim(R), Menactra(R), FluQuadri(R), Adacel(R) and Avaxim(R) 80U. These brands saw combined sales of approx. Rs 426 crore (approx. $51 million) as per IQVIA MAT February 2024. Sanofi will continue to own, manufacture, and import these brands to the country.

M.V. Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), Dr....